Sign inJoin waitlistJoin the waitlist

Stephen Russell

Service Director, Vitreoretinal Diseases and Surgery · University of Iowa Health Care Medical Center

Credentials: · · ·

History

University of Iowa Health Care Medical Center
Present
University of Iowa Health Care Medical Center
Present

University of Iowa
1989–1990
Ophthalmology
University of Miami Hospital and Clinics/Bascom Palmer Eye Institute-Anne Bates Leach Eye Center
1986–1989
Internal Medicine
UCLA David Geffen School of Medicine/UCLA Medical Center
1983–1986
UCLA David Geffen School of Medicine/UCLA Medical Center
1982–1983
David Geffen Sch of Med at UCLA
1978–1982
Electrical Engineering and Biology , Stanford University

Research

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 1,660 citations
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
The Lancet · 2017 · First of 36 authors · Corresponding · 1,570 citations
Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and…
The FASEB Journal · 2000 · 715 citations

James Folk
51 papers
Culver Boldt
41 papers · 15 as a fellow
Elliott Sohn
39 papers · 5 as a fellow
Edwin Stone
35 papers · 10 as a resident
Vinit Mahajan
27 papers
Ian Han
25 papers
Michael Abramoff
25 papers
RM
Robert Mullins
21 papers · 5 as a resident
Karen Gehrs
18 papers
DA
David Almeida
13 papers
Eric Chin
13 papers · 11 as a fellow
Jonathan Russell
12 papers · 8 as a resident

Clinical trials

Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)
Principal investigator · Active not recruiting
Genentech, Inc.
2015–2030